![]() |
市场调查报告书
商品编码
1961339
层析法市场-全球产业规模、份额、趋势、机会、预测:按类型、最终用户、地区和竞争格局划分,2021-2031年Chromatography Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End User, By Region & Competition, 2021-2031F |
||||||
全球层析法市场预计将从 2025 年的 100.3 亿美元大幅成长至 2031 年的 136.9 亿美元,复合年增长率为 5.32%。
层析法仍然是分离复杂混合物中特定成分并进行精确鑑定和纯化的基础分析技术。推动这一成长的主要因素是製药和生物技术产业研发活动的广泛扩展,这些活动需要严格的测试通讯协定来进行药物发现和品质保证。此外,政府对食品安全分析和环境监测的严格监管也迫使实验室采用可靠的分离技术。根据欧洲製药工业协会联合会 (EFPIA) 的报告,预计到 2024 年,欧洲製药业将在研发方面投入约 550 亿欧元,这凸显了巨额投资对先进分析仪器的需求。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 100.3亿美元 |
| 市场规模:2031年 | 136.9亿美元 |
| 复合年增长率:2026-2031年 | 5.32% |
| 成长最快的细分市场 | 液相层析法 |
| 最大的市场 | 北美洲 |
儘管有这些正面因素,但由于先进层析法系统需要大量资本投入,市场仍面临许多障碍。购置和维护高性能设备的高昂成本往往超出小规模合约研究机构和学术组织的财力。这种经济壁垒阻碍了这些技术的广泛应用,也是资源匮乏地区市场扩张的主要障碍。因此,儘管对先进分析技术的需求依然旺盛,但高昂的进入门槛仍然限制着小规模机构更广泛地获取和应用这些技术。
製药和生物技术产业研发投入的成长是全球层析法市场的主要驱动力,尤其是在该行业向复杂生物疗法转型之际。随着各机构专注于开发单株抗体、生物相似药和个人化疗法,对高解析度分离技术的需求显着增加,以确保药物纯度和符合监管要求。这项转变的特征是药物研发管线的大量投资,这些管线大量采用液相层析法和质谱技术进行表征。例如,默克在2024年2月的财务报告中揭露,其2023年全年研发支出达到305亿美元。这代表着对临床专案投资的策略性扩张,直接推动了用于高通量筛检和品管的先进设备的采购。
同时,严格的食品安全和品管标准的实施,要求实验室具备更强的污染物和农药残留检测能力。随着世界各国政府不断降低可接受的限值,高灵敏度的层析法解决方案对于确保合规性和保护消费者至关重要。美国食品药物管理局(FDA) 在 2024 年 3 月发布的 2025 财年总结报告中宣布,已特别申请额外 1,500 万美元用于食源性疾病预防基础设施的现代化改造,凸显了联邦政府致力于提升检测能力的决心。这种法规环境为主要设备製造商提供了稳定的收入来源。例如,安捷伦科技公司 (Agilent Technologies) 2023 年 11 月公布的年销售额为 68.3 亿美元,这表明在这些关键分析需求的驱动下,该行业拥有巨大的经济规模。
购置和维护先进层析法系统所需的大量资本投入是限制全球层析法市场扩张的主要障碍。中小企业,尤其是受託研究机构和学术实验室,往往面临严格的预算限制,使得引进高效液相层析法(HPLC)和气相层析法(GC)设备在经济上难以承受。这种成本壁垒限制了最尖端科技的应用,使其主要局限于资金雄厚的製药公司,从而限制了潜在基本客群,并阻碍了在经济敏感地区的市场渗透。
这些财务限制也反映在近期的产业绩效数据中,数据显示企业不愿采购大规模设备。德国工业协会Spectalis在2024年发布的报告显示,分析、生物和实验室技术领域的国内销售额下降了0.1%,至52.2亿欧元,主要客户行业的投资放缓被认为是造成市场停滞的原因。这一事实凸显了经济谨慎和营运成本飙升如何直接限制了必要分析设备的采购,阻碍了市场实现最大成长。
随着实验室努力遵守国际永续性指南并减少对环境的影响,向绿色层析法和永续溶剂的转型正迅速成为至关重要的趋势。这一趋势包括引入节能设备,旨在用环保替代品取代有害的有机溶剂,并减少废弃物产生。製造商正积极响应这项需求,开发出能够显着降低能源和溶剂消耗,同时保持卓越分析能力的系统。例如,沃特世公司在其2024年12月发布的《环境、社会和管治报告》中宣布,与2016年相比,其范围1和范围2的温室气体排放减少了36%,这表明这些永续战略已在行业内实用化。
同时,人工智慧(AI)在方法优化领域的应用正透过自动化复杂的决策任务和提高数据准确性,彻底改变市场格局。实验室越来越多地使用AI驱动的软体来自主调整分离参数、合併峰值以及预测仪器维护需求,从而有效消除了人工数据解读带来的瓶颈。这项技术进步不仅提升了处理能力,还确保了研究工作流程中更高的品管和可重复性。根据岛津公司截至2024年11月的财年财务报告,该公司获得了总额达1,300亿日圆的订单。这项业绩主要得益于其成功推出了一款配备AI驱动的自动化波形处理功能的新型液相层析法系统。
The Global Chromatography Market is projected to expand significantly, rising from a valuation of USD 10.03 Billion in 2025 to USD 13.69 Billion by 2031, reflecting a compound annual growth rate of 5.32%. Chromatography remains a cornerstone analytical method used to isolate specific components within complex mixtures for accurate identification and purification. A major catalyst for this growth is the extensive broadening of research and development initiatives within the pharmaceutical and biotechnology industries, which demand stringent testing protocols for drug discovery and quality assurance. Furthermore, rigorous government mandates regarding food safety analysis and environmental monitoring are compelling laboratories to acquire dependable separation technologies. As reported by the European Federation of Pharmaceutical Industries and Associations, the pharmaceutical sector in Europe invested approximately €55,000 million in R&D during 2024, highlighting the immense financial commitment that underpins the demand for sophisticated analytical equipment.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 10.03 Billion |
| Market Size 2031 | USD 13.69 Billion |
| CAGR 2026-2031 | 5.32% |
| Fastest Growing Segment | Liquid Chromatography |
| Largest Market | North America |
Despite these positive indicators, the market confronts substantial obstacles due to the steep capital expenditures necessary for advanced chromatographic systems. The significant expense of acquiring and maintaining high-performance instruments often surpasses the financial capabilities of smaller contract research organizations and academic institutions. This economic hurdle impedes the widespread integration of these technologies and acts as a significant barrier to market expansion in regions with limited resources. Consequently, while the demand for advanced analytics is high, the financial burden of entry continues to restrict broader accessibility and adoption across smaller entities.
Market Driver
Escalating expenditure on research and development within the pharmaceutical and biotechnology sectors serves as a dominant engine for the global chromatography market, specifically as the industry pivots toward complex biological therapeutics. As organizations intensify their focus on developing monoclonal antibodies, biosimilars, and personalized treatments, the requirement for high-resolution separation methods to guarantee purity and regulatory adherence has grown substantially. This shift is defined by significant capital investment in discovery pipelines that depend heavily on liquid chromatography and mass spectrometry for characterization. For example, Merck & Co. revealed in its February 2024 financial report that research and development expenses hit $30.5 billion for the full year of 2023, signaling a strategic boost in clinical programs that directly drives the procurement of advanced instrumentation for high-throughput screening and quality control.
Concurrently, the enforcement of rigorous food safety and quality control standards is necessitating that laboratories enhance their ability to detect contaminants and pesticide residues. Governments around the globe are lowering permissible limits, requiring highly sensitive chromatographic solutions to ensure compliance and protect consumers. According to the U.S. Food and Drug Administration's March 2024 budget summary for Fiscal Year 2025, the agency requested a $15 million increase specifically to modernize its infrastructure for preventing foodborne illness, emphasizing a federal commitment to better testing capabilities. This regulatory environment creates a reliable revenue stream for leading instrument providers, as evidenced by Agilent Technologies, which reported full-year revenue of $6.83 billion in November 2023, demonstrating the vast financial scale of the sector supported by these critical analytical needs.
Market Challenge
The substantial capital investment required to purchase and sustain advanced chromatographic systems acts as a major impediment to the expansion of the global chromatography market. Small and medium-sized enterprises, specifically contract research organizations and academic laboratories, frequently face strict budgetary limitations that render the acquisition of high-performance liquid chromatography or gas chromatography instruments financially impractical. This cost-related obstacle confines the utilization of cutting-edge technology primarily to well-resourced pharmaceutical corporations, thereby restricting the potential client base and hindering market penetration in economically sensitive regions.
The consequence of these financial constraints is visible in recent industry performance data, which indicates a reluctance to commit to large-scale equipment acquisitions. As reported by the German industry association Spectaris in 2024, domestic sales for the analytical, bio, and laboratory technology sector fell by 0.1% to €5.22 billion, a stagnation blamed on hesitant investment trends among key customer industries. This evidence highlights how economic prudence and elevated operational expenses are directly limiting the procurement of necessary analytical instrumentation, keeping the market from achieving its maximum growth trajectory.
Market Trends
The transition toward Green Chromatography and Sustainable Solvents is quickly becoming a pivotal trend as laboratories strive to comply with international sustainability directives and decrease their environmental impact. This movement entails substituting toxic organic solvents with environmentally friendly alternatives and deploying energy-efficient equipment engineered to reduce waste production. Manufacturers are addressing this demand by developing systems that preserve superior analytical capabilities while substantially cutting down on energy and solvent consumption. For instance, Waters Corporation noted in its December 2024 Environmental, Social, and Governance Report that it achieved a 36% decrease in Scope 1 and Scope 2 greenhouse gas emissions compared to 2016, demonstrating the real-world application of these sustainable strategies within the industry.
Simultaneously, the incorporation of Artificial Intelligence for Method Optimization is revolutionizing the market by automating intricate decision-making tasks and improving data precision. Laboratories are increasingly utilizing AI-powered software to autonomously refine separation parameters, integrate peaks, and forecast instrument maintenance requirements, effectively eliminating bottlenecks linked to manual data interpretation. This technological evolution not only boosts throughput but also guarantees greater reproducibility in quality control and research workflows. According to Shimadzu's financial results from November 2024, the company secured orders totaling 130.0 billion yen, a performance largely underpinned by the successful launch of new liquid chromatography systems featuring AI-automated waveform processing capabilities.
Report Scope
In this report, the Global Chromatography Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Chromatography Market.
Global Chromatography Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: